Tuesday, October 1, 2024
HomeNews

News

Spexis’ CXCR4 Inhibitor Balixafortide Demonstrates Synergistic Efficacy in Combination With Docetaxel in a Metastatic Prostate Cancer Preclinical Model

SPEXIS AG, a clinical-stage biopharmaceutical company, announced that its CXCR4 inhibitor balixafortide demonstrated synergistic efficacy in combination with docetaxel compared to either drug alone...

Human Horizons Reveals More of Ultra-futuristic Digital GT HiPhi Z

Industry-leading new mobility and intelligent driving technology company, Human Horizons, has recently unveiled more details on the ultra-futuristic digital GT HiPhi Z. Redefining the...

Unilabs Sweden Launches Subtle Medical’s AI-powered Imaging Technology to Further Bolstering Patient Care

Unilabs, the leading diagnostic services provider, announced a partnership with Subtle Medical, a healthcare technology company using artificial intelligence for faster and higher quality...

Arcanna.ai Now Available in AWS Marketplace

Arcanna.ai announced the availability of its AI-Assisted Cybersecurity platform in AWS Marketplace a curated digital catalog from Amazon Web Services (AWS) that customers can...

Azra AI Expands Innovative Incidental Findings Technology to Help Clinicians Identify More Cancers

Azra AI's proprietary software — which uses artificial intelligence (AI) and natural language processing to identify incidental lung nodules in medical reports — is...
0FansLike
0FollowersFollow
spot_img

Hot Topics